Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2021;71:209–249.
   PubMed Web of Science ®Google Scholar
• Graff JN, Chamberlain ED. Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy. Core Evid. 2015;10:1–10.
   PubMed Web of Science ®Google Scholar
• Skrabalak SE, Chen J, Sun Y, et al. Gold nanocages: synthesis, properties, and applications. Acc Chem Res. 2008;41:1587–1595.
   PubMed Web of Science ®Google Scholar
• Chen J, Glaus C, Laforest R, et al. Gold nanocages as photothermal transducers for cancer treatment. Small. 2010;6:811–817.
   PubMed Web of Science ®Google Scholar
• Xia X, Xia Y. Gold nanocages as multifunctional materials for nanomedicine. Front Phys. 2014;9:378–384.
   Web of Science ®Google Scholar
• Huang S, Duan S, Wang J, et al. Folic‐acid‐mediated functionalized gold nanocages for targeted delivery of anti‐miR‐181b in combination of gene therapy and photothermal therapy against hepatocellular carcinoma. Adv Funct Mater. 2016;26:2532–2544.
   Web of Science ®Google Scholar
• Huang S, Liu Y, Xu X, et al. Triple therapy of hepatocellular carcinoma with microRNA-122 and doxorubicin co-loaded functionalized gold nanocages. J Mater Chem B. 2018;6:2217–2229.
   PubMed Web of Science ®Google Scholar
• Zhang H, Gao Z, Li X, et al. Multiple-mRNA-controlled and heat-driven drug release from gold nanocages in targeted chemo-photothermal therapy for tumors. Chem Sci. 2021;12:12429–12436.
   PubMed Web of Science ®Google Scholar
• Almowalad J, Somani S, Laskar P, et al. Lactoferrin-bearing gold nanocages for gene delivery in prostate cancer cells in vitro. Int J Nanomedicine. 2021;16:4391–4407.
   PubMed Web of Science ®Google Scholar
• Lim LY, Koh PY, Somani S, et al. Tumor regression following intravenous administration of lactoferrin-and lactoferricin-bearing dendriplexes. Nanomedicine. 2015;11:1445–1454.
   PubMed Web of Science ®Google Scholar
• Somani S, Robb G, Pickard BS, et al. Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex. J Control Release. 2015;217:235–242.
   PubMed Web of Science ®Google Scholar
• Laskar P, Somani S, Campbell SJ, et al. Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. Nanoscale. 2019;11:20058–20071.
   PubMed Web of Science ®Google Scholar
• Aldawsari H, Edrada-Ebel R, Blatchford DR, et al. Enhanced gene expression in tumors after intravenous administration of arginine-, lysine-and leucine-bearing polypropylenimine polyplex. Biomaterials. 2011;32:5889–5899.
   PubMed Web of Science ®Google Scholar
• Al Robaian M, Chiam KY, Blatchford DR, et al. Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas. Nanomedicine. 2014;9:421–434.
   PubMed Web of Science ®Google Scholar
• Altwaijry N, Somani S, Parkinson JA, et al. Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12. Drug Deliv. 2018;25:679–689.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chiu GN. Dual-functionalized PAMAM dendrimers with improved P-glycoprotein inhibition and tight junction modulating effect. Biomacromolecules. 2013;14:4226–4235.
   PubMed Web of Science ®Google Scholar
• Zinselmeyer BH, Mackay SP, Schätzlein AG, et al. The lower-generation polypropylenimine dendrimers are effective gene-transfer agents. Pharm Res. 2002;19:960–967.
   PubMed Web of Science ®Google Scholar
• Ghosh PS, Kim CK, Han G, et al. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano. 2008;2:2213–2218.
   PubMed Web of Science ®Google Scholar
• Kim ST, Chompoosor A, Yeh YC, et al. Dendronized gold nanoparticles for siRNA delivery. Small. 2012;8:3253–3256.
   PubMed Web of Science ®Google Scholar
• Futaki S, Ohashi W, Suzuki T, et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem. 2001;12:1005–1011.
   PubMed Web of Science ®Google Scholar
• Tencomnao T, Apijaraskul A, Rakkhithawatthana V, et al. Gold/cationic polymer nano-scaffolds mediated transfection for non-viral gene delivery system. Carbohydr Polym. 2011;84:216–222.
   Web of Science ®Google Scholar
• Shan Y, Luo T, Peng C, et al. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. Biomaterials. 2012;33:3025–3035.
   PubMed Web of Science ®Google Scholar
• Wong SY, Pelet JM, Putnam D. Polymer systems for gene delivery—past, present, and future. Prog Polym Sci. 2007;32:799–837.
   Web of Science ®Google Scholar
• Morgan E, Wupperfeld D, Morales D, et al. Shape matters: gold nanoparticle shape impacts the biological activity of siRNA delivery. Bioconjug Chem. 2019;30:853–860.
   PubMed Web of Science ®Google Scholar
• Robinson R, Gerlach W, Ghandehari H. Comparative effect of gold nanorods and nanocages for prostate tumor hyperthermia. J Control Release. 2015;220:245–252.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang L, Wang J, et al. Tunable rigidity of (polymeric core)–(lipid shell) nanoparticles for regulated cellular uptake. Adv Mater. 2015;27:402–1407.
   Web of Science ®Google Scholar
• Liu H, Wang J, Li W, et al. Cellular uptake behaviors of rigidity-tunable dendrimers. Pharmaceutics. 2018;10:99–107.
   PubMed Web of Science ®Google Scholar
• Cho EC, Au L, Zhang Q, et al. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small. 2010;6:517–522.
   PubMed Web of Science ®Google Scholar